Medfinder
Back to blog

Updated: January 25, 2026

What Is Pimecrolimus? Uses, Dosage, and What You Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Large medication capsule with information icon and educational elements

What is pimecrolimus (Elidel) and what is it used for? Learn about this eczema treatment's uses, dosage, how to apply it, and what to expect in 2026.

If your doctor has prescribed pimecrolimus — or you've heard the brand name Elidel — you may be wondering exactly what this medication is and why it's used for eczema. Here's a comprehensive, plain-English overview.

What Is Pimecrolimus?

Pimecrolimus is a prescription topical cream used to treat mild to moderate atopic dermatitis — the medical term for eczema. It belongs to a class of medications called topical calcineurin inhibitors (TCIs). Unlike topical steroids (corticosteroids), pimecrolimus is a non-steroidal medication — it reduces inflammation through a different mechanism that doesn't cause skin thinning.

Brand name: Elidel (manufactured for Bausch Health). Generic pimecrolimus 1% cream is also available from multiple manufacturers, including Teva.

The FDA approved pimecrolimus on December 13, 2001, making it one of the first non-steroidal prescription treatments for eczema.

What Is Pimecrolimus Used For?

Pimecrolimus is FDA-approved as second-line therapy for mild to moderate atopic dermatitis in non-immunocompromised adults and children 2 years of age and older who have:

Failed to respond adequately to other topical prescription treatments (usually topical corticosteroids), OR

Cannot tolerate or should not use topical steroids in the area being treated (e.g., face, eyelids, skin folds)

It is specifically intended for short-term and non-continuous chronic treatment — not for long-term daily use.

Off-Label Uses of Pimecrolimus

Beyond its FDA-approved indication, pimecrolimus is also used off-label (meaning prescribed by a doctor for a use not officially approved by the FDA) for several conditions:

Seborrheic dermatitis (dandruff-related skin inflammation)

Cutaneous lupus erythematosus

Oral lichen planus (an inflammatory condition of the mucous membranes)

Vitiligo (particularly for repigmentation maintenance)

Perioral dermatitis

How Is Pimecrolimus Used? Dosage and Application Instructions

Pimecrolimus is available only as a 1% cream, applied to the skin. It comes in 30-gram, 60-gram, and 100-gram tubes. Standard dosing:

Adults and children 2+: Apply a thin layer to the affected skin areas twice daily

Duration: Use for up to 6 weeks continuously; re-evaluate if no improvement at 6 weeks

Areas: Can be applied to all affected areas including face, neck, and skin folds — but not inside the nose, eyes, mouth, or genitals

Stop use: When symptoms (itch, rash, redness) resolve — don't continue indefinitely just to maintain clear skin

How to Apply Pimecrolimus Correctly

Wash your hands before applying

Make sure the skin is dry (don't apply immediately after bathing)

Apply a thin layer and rub in gently and completely

Wash hands after application (unless you're treating eczema on your hands)

Don't cover with bandages or wraps — regular clothing is fine

Wait before bathing or swimming after application

Is Pimecrolimus a Steroid?

No. Pimecrolimus is not a corticosteroid (steroid). It belongs to a completely different drug class — topical calcineurin inhibitors. Unlike steroids, pimecrolimus does not cause skin atrophy (thinning) or other steroid-related side effects with use on delicate skin areas. This is one of its key clinical advantages for long-term eczema management on the face and skin folds.

Who Should Not Use Pimecrolimus?

Children under 2 years of age (not FDA-approved)

Patients who are immunocompromised (HIV, organ transplant recipients, etc.)

Patients with Netherton's syndrome

Patients with active bacterial or viral skin infections at the application site

Anyone allergic to pimecrolimus or any inactive ingredient in the cream

Want to understand how pimecrolimus actually works in your body? Read our plain-English guide to pimecrolimus's mechanism of action.

Frequently Asked Questions

Pimecrolimus 1% cream (brand name Elidel) is FDA-approved for the short-term treatment of mild to moderate atopic dermatitis (eczema) in adults and children 2 years and older who have tried other topical treatments without adequate success. It is a non-steroidal topical calcineurin inhibitor.

Yes. Elidel is the brand name for pimecrolimus 1% cream, originally developed by Novartis and now manufactured for Bausch Health. Generic pimecrolimus 1% cream (from Teva and other manufacturers) is therapeutically equivalent to Elidel and typically less expensive.

Many patients notice improvement in itch and redness within the first week of twice-daily use. Significant improvement in the appearance of the rash is often seen within 2–4 weeks. If no improvement occurs within 6 weeks, contact your doctor for re-evaluation.

Yes. Pimecrolimus can be applied to all affected skin areas including the face, eyelids, and neck. This is one of its key advantages over topical steroids — it does not cause skin thinning, making it suitable for long-term use on delicate facial and eyelid skin.

Yes. Generic pimecrolimus 1% cream is available from multiple manufacturers including Teva. It is therapeutically equivalent to brand Elidel and significantly less expensive — as low as $70–$80 with GoodRx or SingleCare coupons for a 30g tube.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Pimecrolimus also looked for:

33,257 have already found their meds with Medfinder.

Start your search today.

33K+
5-star ratingTrusted by 33,257 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?